These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9011645)

  • 21. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat.
    Kolodgie FD; Farb A; Litovsky SH; Narula J; Jeffers LA; Lee SJ; Virmani R
    J Mol Cell Cardiol; 1997 Sep; 29(9):2403-14. PubMed ID: 9299364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of the myocardium during global ischemia. Is crystalloid cardioplegia effective in the immature myocardium?
    Avkiran M; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):220-8. PubMed ID: 2915557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Maruyama Y; Chambers DJ
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ischemic preconditioning prevents endothelial dysfunction, P-selectin expression, and neutrophil adhesion by preventing endothelin and O2- generation in the post-ischemic guinea-pig heart.
    Duda M; Czarnowska E; Kurzelewski M; Konior A; Beresewicz A
    J Physiol Pharmacol; 2006 Dec; 57(4):553-69. PubMed ID: 17229981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-dose crystalloid cardioplegia preserves intracellular sodium homeostasis in myocardium.
    Schepkin VD; Choy IO; Budinger TF; Young JN; DeCampli WM
    J Mol Cell Cardiol; 1999 Sep; 31(9):1643-51. PubMed ID: 10471348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced coronary vascular turgor effect on post-ischemic diastolic function in hypertrophied hearts.
    Yamamoto H; Yamamoto F; Ichikawa H
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):605-8. PubMed ID: 19589788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
    Headrick JP
    J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous adenosine, supplied transiently during reperfusion, ameliorates depressed endogenous adenosine production in the post-ischemic rat heart.
    Smolenski RT; Simmonds HA; Chambers DJ
    J Mol Cell Cardiol; 1997 Jan; 29(1):333-46. PubMed ID: 9040048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution.
    Fujii M; Chambers DJ
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):619-27. PubMed ID: 22715477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial glycogen depletion cannot explain the cardioprotective effects of ischemic preconditioning in the rat heart.
    Asimakis GK
    J Mol Cell Cardiol; 1996 Mar; 28(3):563-70. PubMed ID: 9011639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributory mechanisms for the beneficial effects of myocyte preconditioning during cardioplegic arrest.
    O SJ; Zellner JL; Cox MH; Hebbar L; Brothers TE; Mukherjee R; Tempel GE; Dorman BH; Crawford FA; Spinale FG
    Circulation; 1996 Nov; 94(9 Suppl):II389-97. PubMed ID: 8901780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role?
    Fujii M; Chambers DJ
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):821-31. PubMed ID: 16242951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischaemic postconditioning: does cardioplegia influence protection?
    Maruyama Y; Chambers DJ
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):530-9. PubMed ID: 22345279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.
    Grover GJ; Dzwonczyk S; Sleph PG; Sargent CA
    J Pharmacol Exp Ther; 1993 May; 265(2):559-64. PubMed ID: 8496806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can ischemic preconditioning ensure optimal myocardial protection when delivery of cardioplegia is impaired?
    Galiñanes M; Argano V; Hearse DJ
    Circulation; 1995 Nov; 92(9 Suppl):II389-94. PubMed ID: 7586443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
    Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
    Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is potassium channel opening an effective form of preconditioning before cardioplegia?
    Menasché P; Mouas C; Grousset C
    Ann Thorac Surg; 1996 Jun; 61(6):1764-8. PubMed ID: 8651781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart.
    Takahashi Y; Shibata T; Sasaki Y; Hirai H; Takemura S; Minamiyama Y; Sakaguchi M; Suehiro S
    Osaka City Med J; 2007 Jun; 53(1):9-16. PubMed ID: 17867629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioprotective effects of mitochondrial KATP channels activated at different time.
    Wei K; Min S; Long C
    Chin Med J (Engl); 2004 May; 117(5):647-51. PubMed ID: 15161527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbohydrates and purines in underperfused hearts, protected by ischemic preconditioning.
    de Jonge R; Bradamante S; Speleman L; Willem de Jong J
    J Mol Cell Cardiol; 1998 Mar; 30(3):699-708. PubMed ID: 9515044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.